Abstract
Purpose
To compare hepatobiliary phase (HBP) images obtained 10 and 20 min after Gd-EOB-DTPA-enhanced MRI for liver function assessment in clinic on 3.0 T MR imaging.
Methods
103 patients were separated into four groups: 38 patients for the normal liver function (NLF) group, 33 patients for the liver cirrhosis with Child–Pugh A (LCA) group, 21 patients for the liver cirrhosis with Child–Pugh B group, and 11 patients for a liver cirrhosis with Child–Pugh C group. T1 relaxation times (T1rt) were measured on T1 mapping and reduction rates of T1rt (rrT1rt) were calculated. HBP images were obtained at the 10- and 20-min mark after Gd-EOB-DTPA enhancement.
Results
T1rt on pre-enhancement imaging showed no significant difference (p > 0.05) among all four groups. T1rt for both the 10-min HBP and the 20-min HBP showed a significant difference (p < 0.05) among all groups, but showed no significant difference (p > 0.05) between the NLF group and the LCA group. T1rt and rrT1rt showed no significant difference (p > 0.05) between 10-min HBP and 20-min HBP among all groups. The ROC analysis on 10-min HBP and 20-min HBP showed a lower diagnostic performance between NLF group and LCA group (AUC from 0.532 to 0.582), but high diagnostic performance (AUC from 0.788 to 1.000) among others group.
Conclusions
In comparing 10-min HBP and 20-min HBP T1 mapping after Gd-EOB-DTPA enhancement, our results suggest that 10-min HBP T1 mapping is a feasible option for quantitatively assessing liver function.
Similar content being viewed by others
Abbreviations
- AUC:
-
Area under the curve
- CNR:
-
Contrast-to-noise ratio
- Gd-EOB-DTPA:
-
Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid
- HBP:
-
Hepatobiliary phase
- MRI:
-
Magnetic resonance imaging
- MELD:
-
Model for end-stage liver disease
- ROC:
-
Receiver operating characteristic
- ROI:
-
Region of interest
- rrT1rt:
-
Reduction rate of T1 relaxation time
- SI:
-
Signal intensity
- SNR:
-
Signal-to-noise ratio
- T1rt:
-
T1 relaxation time
References
Kim T, Murakami T, Hasuike Y, et al. (1997) Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA. J Magn Reson Imaging 7(4):683–688
Shimizu J, Dono K, Gotoh M, et al. (1999) Evaluation of regional liver function by gadolinium-EOB-DTPA-enhanced MR imaging. Dig Dis Sci 44(7):1330–1337
Hamm B, Staks T, Muhler A, et al. (1995) Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 195(3):785–792. doi:10.1148/radiology.195.3.7754011
Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, et al. (1992) Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 183(1):59–64. doi:10.1148/radiology.183.1.1549695
Haimerl M, Schlabeck M, Verloh N, et al. (2016) Volume-assisted estimation of liver function based on Gd-EOB-DTPA-enhanced MR relaxometry. Eur Radiol 26(4):1125–1133. doi:10.1007/s00330-015-3919-5
Verloh N, Utpatel K, Haimerl M, et al. (2015) Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: a histopathologic correlation. Sci Rep 5:15408. doi:10.1038/srep15408
Durand F, Valla D (2005) Assessment of the prognosis of cirrhosis: child–pugh versus MELD. J Hepatol 42(Suppl (1)):S100–107. doi:10.1016/j.jhep.2004.11.015
Takamura T, Motosugi U, Ichikawa S, et al. (2016) Usefulness of MR elastography for detecting clinical progression of cirrhosis from child–pugh class A to B in patients with type C viral hepatitis. J Magn Reson Imaging . doi:10.1002/jmri.25182
Horsthuis K, Nederveen AJ, de Feiter MW, et al. (2009) Mapping of T1-values and Gadolinium-concentrations in MRI as indicator of disease activity in luminal Crohn’s disease: a feasibility study. J Magn Reson Imaging 29(2):488–493. doi:10.1002/jmri.21535
Shah NJ, Neeb H, Zaitsev M, et al. (2003) Quantitative T1 mapping of hepatic encephalopathy using magnetic resonance imaging. Hepatology 38(5):1219–1226. doi:10.1053/jhep.2003.50477
Yoshimura N, Saito K, Saguchi T, et al. (2013) Distinguishing hepatic hemangiomas from metastatic tumors using T1 mapping on gadoxetic-acid-enhanced MRI. Magn Reson Imaging 31(1):23–27. doi:10.1016/j.mri.2012.06.026
Bae KE, Kim SY, Lee SS, et al. (2012) Assessment of hepatic function with Gd-EOB-DTPA-enhanced hepatic MRI. Dig Dis 30(6):617–622. doi:10.1159/000343092
Ding Y, Rao SX, Meng T, et al. (2014) Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease. Eur Radiol 24(4):959–966. doi:10.1007/s00330-014-3096-y
Katsube T, Okada M, Kumano S, et al. (2011) Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Investig Radiol 46(4):277–283. doi:10.1097/RLI.0b013e318200f67d
Haimerl M, Verloh N, Fellner C, et al. (2014) MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score. Sci Rep 4:5621. doi:10.1038/srep05621
Ding Y, Rao SX, Chen C, Li R, Zeng MS (2015) Assessing liver function in patients with HBV-related HCC: a comparison of T(1) mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI. Eur Radiol 25(5):1392–1398. doi:10.1007/s00330-014-3542-x
Yoon JH, Lee JM, Paek M, Han JK, Choi BI (2016) Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging. Eur Radiol 26(6):1775–1782. doi:10.1007/s00330-015-3994-7
Van Beers BE, Pastor CM, Hussain HK (2012) Primovist, Eovist: what to expect? J Hepatol 57(2):421–429. doi:10.1016/j.jhep.2012.01.031
van Montfoort JE, Stieger B, Meijer DK, et al. (1999) Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther 290(1):153–157
Planchamp C, Montet X, Frossard JL, et al. (2005) Magnetic resonance imaging with hepatospecific contrast agents in cirrhotic rat livers. Investig Radiol 40(4):187–194
Reimer P, Rummeny EJ, Shamsi K, et al. (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199(1):177–183. doi:10.1148/radiology.199.1.8633143
Tamada T, Ito K, Higaki A, et al. (2011) Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers. Eur J Radiol 80(3):e311–316. doi:10.1016/j.ejrad.2011.01.020
Sofue K, Tsurusaki M, Tokue H, Arai Y, Sugimura K (2011) Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 and 20 min after injection for the detection of liver metastases from colorectal carcinoma. Eur Radiol 21(11):2336–2343. doi:10.1007/s00330-011-2197-0
Ramalho M, Heredia V, Tsurusaki M, Altun E, Semelka RC (2009) Quantitative and qualitative comparison of 1.5 and 3.0 Tesla MRI in patients with chronic liver diseases. J Magn Reson Imaging 29(4):869–879. doi:10.1002/jmri.21719
Tsurusaki M, Semelka RC, Zapparoli M, et al. (2009) Quantitative and qualitative comparison of 3.0T and 1.5T MR imaging of the liver in patients with diffuse parenchymal liver disease. Eur J Radiol 72(2):314–320. doi:10.1016/j.ejrad.2008.07.027
Kamimura K, Fukukura Y, Yoneyama T, et al. (2014) Quantitative evaluation of liver function with T1 relaxation time index on Gd-EOB-DTPA-enhanced MRI: comparison with signal intensity-based indices. J Magn Reson Imaging 40(4):884–889. doi:10.1002/jmri.24443
Haimerl M, Verloh N, Zeman F, et al. (2013) Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI. PloS ONE 8(12):e85658. doi:10.1371/journal.pone.0085658
Cassinotto C, Feldis M, Vergniol J, et al. (2015) MR relaxometry in chronic liver diseases: comparison of T1 mapping, T2 mapping, and diffusion-weighted imaging for assessing cirrhosis diagnosis and severity. Eur J Radiol 84(8):1459–1465. doi:10.1016/j.ejrad.2015.05.019
Acknowledgements
Thanks for Dr. Kyongtae Bae and Dr. Cheng Tao from University of Pittsburgh Medical Centre for giving comments.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study was funded by the National Natural Science Foundation of China (Grant No. 81260214), the State Key Program of Health Care of Guangxi (Grant No. 2012080), and the Innovation Project of Guangxi Graduate Education (Grant No. YCBZ2015029).
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Zhou, ZP., Long, LL., Qiu, WJ. et al. Comparison of 10- and 20-min hepatobiliary phase images on Gd-EOB-DTPA-enhanced MRI T1 mapping for liver function assessment in clinic. Abdom Radiol 42, 2272–2278 (2017). https://doi.org/10.1007/s00261-017-1143-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-017-1143-2